Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Qiagen (QGEN) over the last 6 years, with Q4 2025 value amounting to $1.0 million.

  • Qiagen's Amortization of Deferred Charges fell 6664.47% to $1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 million, marking a year-over-year decrease of 8172.89%. This contributed to the annual value of $3.4 million for FY2025, which is 8172.89% down from last year.
  • According to the latest figures from Q4 2025, Qiagen's Amortization of Deferred Charges is $1.0 million, which was down 6664.47% from $1.2 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Amortization of Deferred Charges ranged from a high of $8.6 million in Q2 2023 and a low of $492000.0 during Q1 2025
  • In the last 5 years, Qiagen's Amortization of Deferred Charges had a median value of $8.0 million in 2021 and averaged $5.9 million.
  • Per our database at Business Quant, Qiagen's Amortization of Deferred Charges skyrocketed by 461.03% in 2022 and then tumbled by 9026.71% in 2025.
  • Over the past 5 years, Qiagen's Amortization of Deferred Charges (Quarter) stood at $8.2 million in 2021, then increased by 4.61% to $8.6 million in 2022, then plummeted by 41.48% to $5.0 million in 2023, then plummeted by 39.49% to $3.0 million in 2024, then plummeted by 66.64% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q4 2025, $1.2 million for Q3 2025, and $632000.0 during Q2 2025.